0001209191-22-039680.txt : 20220628 0001209191-22-039680.hdr.sgml : 20220628 20220628191158 ACCESSION NUMBER: 0001209191-22-039680 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220516 FILED AS OF DATE: 20220628 DATE AS OF CHANGE: 20220628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WELCH DANIEL G CENTRAL INDEX KEY: 0001206199 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39351 FILM NUMBER: 221051404 MAIL ADDRESS: STREET 1: 4611 UNIVERSITY DR STREET 2: 4 UNIVERSITY PLACE CITY: DURHAM STATE: NC ZIP: 27707 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvation Bio Inc. CENTRAL INDEX KEY: 0001811063 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850862255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 357 TEHAMA STREET, FLOOR 3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 754-3517 MAIL ADDRESS: STREET 1: 357 TEHAMA STREET, FLOOR 3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: Panacea Acquisition Corp DATE OF NAME CHANGE: 20200430 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-05-16 2022-05-18 0 0001811063 Nuvation Bio Inc. NUVB 0001206199 WELCH DANIEL G C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036 1 0 0 0 Stock Option (Right to Buy) 4.05 2022-05-16 4 A 0 140713 0.00 A 2032-05-15 Class A Common Stock 140713 140713 D 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 16, 2023); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. This amendment is being filed solely to correct the number of shares covered by the stock option granted on May 16, 2022, which was erroneously reported in the original Form 4 due to an administrative error. Daniel G. Welch, by /s/ Ron A. Metzger, Attorney-in-Fact 2022-06-28